Clinical Trials Directory

Trials / Unknown

UnknownNCT05150301

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea Outside a Level III Maternity Hospital in Alsace

Status
Unknown
Phase
Study type
Observational
Enrollment
134 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
32 Weeks
Healthy volunteers
Not accepted

Summary

An "outborn" birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike "inborn" births). This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called "outborn" births. The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age \<32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.

Conditions

Timeline

Start date
2021-11-01
Primary completion
2022-10-01
Completion
2022-10-30
First posted
2021-12-09
Last updated
2021-12-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05150301. Inclusion in this directory is not an endorsement.